Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”) (the “Company” or “Isodiol”), a global CBD innovator and market leader, is proud to announce that it has entered into an agreement with David Hawk, fitness expert and a former IFBB professional bodybuilder, who ranked in the top 10 of the world’s best professional bodybuilders from 1985 to 1992. Hawk will focus on business development of the Company’s wholly owned subsidiary, ISO-Sport, and will be instrumental in raising further awareness of the Company’s health and wellness CBD products for athletes around the world.

David Hawk is considered one of the world’s best professional trainers and nutrition coaches, and has worked with athletes in the NFL, NHL, PKA, IFL, NASCAR, WWE, TNA and UFC. In addition, he served as a NASCAR Busch Series pit crew trainer for GNC’s and Stackers teams, and advisor for DuPont’s (Nutrition and Health) Sports Nutrition division with Hendricks Motor Sports racing.


Over the past 25 years Mr. Hawk has worked as a consultant marketing specialist and business development director and ingredient educator for some of the largest health and wellness nutrition retailers, manufacturers and publishers in the world, including DuPont Nutrition and Health, Interhealth-USA, Milk Specialties, IDF, GNC, Vitamin Shoppe, Basic Media Group, AFFES Military Exchange, 7-eleven, Giant Eagle, and CVS pharmacies.

“It is truly a privilege to have David Hawk join the Iso-Sport Team,” said CEO of Isodiol, Marcos Agramont.  “This is another example of our dedication to bring Iso-Sport CBD Performance Products to athletes around the globe.”

Mr. Hawk has also been a featured guest on Fox Sports Net’s Totally NASCAR, Sally Jesse Raphael, Regis Philbin, PM Magazine, ESPN, ESPN2, ESPN’s American Muscle Magazine, Muscle Sport USA, Benny Hinn Ministries, and Pat Robertson’s CBN 700 Club.

As a celebrity athlete, Mr. Hawk has published fitness and nutrition articles in national and international magazines including Muscle & Fitness, Flex, Ironman, Men’s Health, Muscular Development, Muscle Mag International, Muscle Training Illustrated, Physical, Get Active, Let’s Live, Fitness RX, Black Belt, Physique 3D, Muscle and Body, Wellbella, Real Fighter, Giant Eagle’s Healthy Advantage magazine, and the Europa World Sports magazines.

With the addition of Mr. Hawk to the Iso-Sport Team, the Company is confident it has added another strong pillar to its already solid foundation of relationships, such as Olympic Athlete AmbassadorsCage Warriors, and the Iso-Sport Living Lab for athletes and trainers with Altis, in its quest to be the global leader in CBD Performance Products to athletes around the world.

For more information on Iso-Sport, please visit: www.iso-sport.com or follow us on social media at:

https://www.instagram.com/isosportnow/?hl=en

https://www.facebook.com/isosportnow/

About Isodiol International Inc.

Isodiol International Inc. is the market leader in pharmaceutical grade pure, natural CBD and the industry leader in the manufacturing and development of CBD consumer products.

Isodiol is the pioneer of many firsts in the CBD industry, including the commercialization of 99%+ pure, natural isolated CBD, micro-encapsulations, and nanotechnology for the highest quality consumable and topical skin care products. Most recently, the Company received approval for its CBD designated as an Active Pharmaceutical Ingredient for use in Finished Pharmaceutical Products, as was announced on April 26, 2018.

Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs and continued international expansion into Latin America, Asia, and Europe.

Join Us On Facebook: https://www.facebook.com/IsodiolInternationalInc/
Twitter: @Isodiolintlinc

ON BEHALF OF THE BOARD
Marcos Agramont, CEO & Director

INVESTOR RELATIONS:
Ir@isodiol.com
www.isodiol.com

Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation and does not intend, to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.

The CSE has not reviewed, approved or disapproved the content of this press release.

Click here to connect with Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”) for an Investor Presentation. 

Source: globenewswire.com

In the evolving rush of mergers and acquisitions (M&A) in the Canadian cannabis market, Canopy Growth (NASDAQ:CGC,TSX:WEED) announced it will acquire The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) in a deal worth approximately C$435 million.

Meanwhile, a cannabis operator in the US confirmed this week that it will receive a financial boost from a partner to solidify its position in the burgeoning Pennsylvania state market.

Keep reading... Show less

The Board of Directors of Aphria Unanimously Recommends Shareholders Vote “For” the Arrangement

Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination

Keep reading... Show less

Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), one of the UK’s leading CBD and Hemp product suppliers, announces that as part of the equity fundraise announced yesterday, Antony Calamita and Andrew Male, Directors of the Company, subscribed for 285,714 Ordinary Shares and 1,428,571 Ordinary Shares respectively. The subscriptions are at a price of 3.5 pence per ordinary share for a total of £60,000. Following these subscriptions, Antony Calamita is now interested in 54,385,714 Ordinary Shares, representing 8.61% of the Company’s share capital as increased by the fundraising, and Andrew Male is now interested in 6,138,196 Ordinary Shares, representing 0.97% of the Company’s issued share capital as increased by the fundraising

Further, the timetable for receipt of applications under the Broker Option, which was also announced yesterday, has been extended until 5:00 pm 9 April 2021 to capture additional interest which was unable to be completed yesterday.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, would like to provide the following dial-in information for the Company’s upcoming Annual and Special Meeting (the “Meeting”) scheduled to be held at 11:00 a.m. Eastern Daylight Time on April 12, 2021. Shareholders and proxyholders may access the Meeting via teleconference by dialing 647-723-3984 or 1-866-365-4406 from Canada or the United States, then entering participation code “8487744” followed by the pound (“#”) sign.

In consideration of the COVID-19 pandemic and the recent restrictions imposed by the Ontario Provincial Government, shareholders and proxyholders will only be able to attend the Meeting via teleconference and will not be permitted to attend the Meeting in person at the address provided on the Notice of Annual and Special Meeting of Shareholders.

Keep reading... Show less

Gage Growth Corp. (“Gage” or the “Company”) (CSE:GAGE), a leading high-quality craft cannabis brand and operator in Michigan, announced today that it has signed an agreement with Blue River™ Extracts & Terpenes (“Blue River™”) to bring the brand’s award-winning solventless technology and other trademark branded products to the state’s medical patients and cannabis consumers. The Company will have exclusive rights to Blue River™’s premium product offerings in Michigan.

Keep reading... Show less